Preceptis Medical Appoints Dave Carey as Chief Executive Officer to Lead Next Phase of Strategic Growth

MINNEAPOLIS--(BUSINESS WIRE)--Preceptis Medical, Inc., a commercial-stage medical technology company transforming pediatric ENT care, today announced the appointment of Dave Carey as Chief Executive Officer. Carey assumes leadership as the company accelerates toward full market release of its flagship product, the Hummingbird^® Tympanostomy Tube System (TTS).

“We are thrilled to welcome Dave Carey to Preceptis,” said John Seaberg, Chairman of the Board at Preceptis Medical. “His deep industry expertise, strategic vision, and dedication to improving patient care make him the ideal leader to guide our next phase of growth.”

As CEO, Carey will oversee the continued expansion of the Hummingbird TTS System in the U.S., which enables in-office pediatric ear tube placement without the need for general anesthesia. The device has already demonstrated significant clinical, economic, and patient satisfaction benefits in the company’s limited market release.

“I’m honored to join the Preceptis Medical team at such an important moment,” said Dave Carey. “Hummingbird represents a true shift in how we approach pediatric ear tube procedures, and I look forward to partnering with our talented team and surgeon community to bring this solution to more families nationwide.”

Preceptis Medical’s Hummingbird system enables in-office ear tube placement for young children without the need for general anesthesia, representing a safer, more cost-effective, and family-centered approach to care. For more information, visit www.preceptismedical.com.